HRH3 and cognitive disorder: For example, novel H3R antagonist/inverse agonist, CEP-26401, has been displayed to elicit amnesic effects in rodent models and have a potential utility in cognitive disorder, attention disorder, and adjunctive treatment for schizophrenia (Raddatz et al., 2012).